ITGA2 and ovarian cancer: Our ITGA2 site-specific determination of total glycosylation revealed also 7 N-glycosylation sites and 5 sialylation sites (N343, N460, N475, N699, and N1057) spanning the entire structural domains of ITGA2 with complex type sialylated glycans in human ovarian cancer cells (Figure 2C).